Upstream Bio (UPB) Current Assets (2023 - 2026)

Upstream Bio's Current Assets history runs 4 years deep, the most recent figure standing at $316.3 million for Q1 2026.

• In Q1 2026, Current Assets fell 30.3% year-over-year to $316.3 million; the TTM figure through Mar 2026 stood at $316.3 million (down 30.3% YoY), while the FY2025 annual figure was $351.8 million, down 26.58% from the prior year.
• Current Assets was $316.3 million for Q1 2026 at Upstream Bio, down from $351.8 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $479.2 million in Q4 2024 to a low of $117.0 million in Q4 2023.
• Historically, Current Assets has averaged $344.1 million across 4 years, with a median of $370.4 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Current Assets jumped 309.55% in 2024, then slumped 30.3% in 2026.
• A 4-year view of Current Assets shows it stood at $117.0 million in 2023, then surged by 309.55% to $479.2 million in 2024, then declined by 26.58% to $351.8 million in 2025, then retreated by 10.1% to $316.3 million in 2026.
• The last three Current Assets figures came in at $316.3 million (Q1 2026), $351.8 million (Q4 2025), and $389.0 million (Q3 2025), per Business Quant data.